AL
ALC.AU Alcidion Group Ltd
- Market cap
- AUD 148M
- P/E
- -
- P/B
- 1.63x
- ROE
- 2.5%
- Dividend yield
- -
- Fundamental score
- 2.0/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ALC.AU undervalued?
Graham numberThe Graham number of Alcidion Group Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alcidion Group Ltd fundamental analysis
10 of 22 checks passedROE 0/2
Low return on equity (2.5%), below 10%.
ROA 1/1
Return on assets (1.9%) is above the industry median (-45.6%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (38.1%) is above the industry median (18.9%).
Revenue Growth 1/2
Revenue grew 8.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (0.9%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 24.1x against interest expense, well covered.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (1.6x) is below the industry median (5.7x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Alcidion Group Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Alcidion Group Ltd
Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also pro…
Full company profileAlcidion Group Ltd financial statements
Alcidion Group Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 3.46M | 4.18M | 16.9M | 18.6M | 25.9M | 34.4M | 40.4M | 37.1M | 40.8M | 51.6M |
| Gross Profit | 2.28M | 1.40M | 5.91M | 401K | 3.52M | 3.30M | 1.25M | 31.9M | 36.0M | 9.16M |
| Operating Income | -2.14M | -2.21M | -125K | -2.32M | -174K | -1.73M | -4.73M | -7.65M | 7.81M | 2.55M |
| EBITDA | -3.06M | -3.12M | -91.8K | -3.85M | -474K | -1.58M | -1.43M | -4.50M | 4.03M | 2.55M |
| Net Income | -2.06M | -2.09M | -84.2K | -3.08M | -2.24M | -4.41M | -3.62M | -8.42M | 1.65M | 2.29M |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 6.83M | 5.83M | 24.9M | 39.4M | 58.4M | 128M | 121M | 114M | 116M | 122M |
| Total Liabilities | 1.41M | 2.50M | 11.6M | 9.70M | 13.2M | 34.4M | 30.5M | 27.5M | 27.8M | 31.0M |
| Shareholders' Equity | 5.42M | 3.33M | 13.2M | 29.7M | 45.2M | 94.0M | 90.2M | 86.9M | 87.8M | 90.9M |
| Cash & Short-term Investments | 5.33M | 2.89M | 3.17M | 15.9M | 25.0M | 17.3M | 14.6M | 11.8M | 17.7M | 20.6M |
| Total Debt | - | - | - | 316K | 181K | 2.48M | 2.16M | 1.70M | 1.41M | 814K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -519K | -1.83M | 1.99M | -2.02M | 1.55M | 996K | 169K | -7.13M | 5.76M | 6.85M |
| Capital Expenditure | 14.6K | 23.9K | 265K | 124K | 313K | 311K | 454K | 53.0K | 125K | 226K |
| Free Cash Flow | -534K | -1.85M | 1.73M | -2.14M | 1.23M | 685K | -285K | -7.18M | 5.64M | 6.62M |
| Ratios | ||||||||||
| ROE | -38.0% | -62.7% | -0.6% | -10.3% | -5.0% | -4.7% | -4.0% | -9.7% | 1.9% | 2.5% |
| ROA | -30.2% | -35.8% | -0.3% | -7.8% | -3.8% | -3.4% | -3.0% | -7.4% | 1.4% | 1.9% |
| Net Profit Margin | -59.6% | -50.0% | -0.5% | -16.6% | -8.7% | -12.8% | -9.0% | -22.7% | 4.1% | 4.4% |
| Debt to Equity | - | - | - | 0.01x | 0.00x | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Alcidion Group Ltd dividends
Alcidion Group Ltd has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10 on Nov 16, 2026.
Who owns Alcidion Group Ltd
- Insiders 26.62%
- Institutions 8.70%
- Public & others 64.68%
- Shares outstanding 1.35B
- Free float 984M
Alcidion Group Ltd company profile
- Company name
- Alcidion Group Ltd
- Ticker
- ALC.AU
- ISIN
- AU000000ALC6
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 141
- Fiscal year end
- June
- Address
- 9 Yarra Street, South Yarra, VIC, Australia, 3141
- Phone
- 61 18 0076 7873
- Website
- alcidion.com
About Alcidion Group Ltd
Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.
Alcidion Group Ltd management
10- Ms. Kate QuirkeGroup MD, CEO & Executive Director
- Mr. Matthew GeppChief Financial Officer
- Ms. Julia StevensChief Operating Officer
- Mr. Sean WalkerChief Technology Officer
- Mr. Nick WhiteChief Marketing Officer
- Ms. Amanda JamesChief People Officer
- Ms. Kaye HockingChief Product Officer
- Dr. Paul DeffleyChief Medical Officer & MD of UK
- Ms. Tracy McClellandChief Clinical Information Officer
- Mr. Michael Sapountzis AGIA, B.Com., L.L.B., M.A.I.C.D.Company Secretary